RU2330838C2 - Способ получения 2-циан-3-гидрокси-n-(фенил) бут-2-енамидов - Google Patents
Способ получения 2-циан-3-гидрокси-n-(фенил) бут-2-енамидов Download PDFInfo
- Publication number
- RU2330838C2 RU2330838C2 RU2005132162/04A RU2005132162A RU2330838C2 RU 2330838 C2 RU2330838 C2 RU 2330838C2 RU 2005132162/04 A RU2005132162/04 A RU 2005132162/04A RU 2005132162 A RU2005132162 A RU 2005132162A RU 2330838 C2 RU2330838 C2 RU 2330838C2
- Authority
- RU
- Russia
- Prior art keywords
- formula
- compound
- solvent
- sodium
- acetic anhydride
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 47
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 15
- 239000002904 solvent Substances 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 12
- 239000000725 suspension Substances 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 9
- 239000007787 solid Substances 0.000 claims abstract description 7
- 239000002585 base Substances 0.000 claims abstract description 6
- 239000003513 alkali Substances 0.000 claims abstract description 4
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims abstract description 3
- 150000001408 amides Chemical class 0.000 claims abstract description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 3
- 150000002902 organometallic compounds Chemical class 0.000 claims abstract description 3
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 claims abstract description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims abstract description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims abstract 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 8
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims description 6
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 claims description 4
- KLKFAASOGCDTDT-UHFFFAOYSA-N ethoxymethoxyethane Chemical compound CCOCOCC KLKFAASOGCDTDT-UHFFFAOYSA-N 0.000 claims description 4
- AUFVJZSDSXXFOI-UHFFFAOYSA-N 2.2.2-cryptand Chemical compound C1COCCOCCN2CCOCCOCCN1CCOCCOCC2 AUFVJZSDSXXFOI-UHFFFAOYSA-N 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 3
- 150000002430 hydrocarbons Chemical class 0.000 claims description 3
- 239000003444 phase transfer catalyst Substances 0.000 claims description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 239000000010 aprotic solvent Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 150000003983 crown ethers Chemical class 0.000 claims description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- 150000008282 halocarbons Chemical class 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 claims description 2
- 239000005453 ketone based solvent Substances 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 150000004714 phosphonium salts Chemical class 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 2
- IBWGNZVCJVLSHB-UHFFFAOYSA-M tetrabutylphosphanium;chloride Chemical compound [Cl-].CCCC[P+](CCCC)(CCCC)CCCC IBWGNZVCJVLSHB-UHFFFAOYSA-M 0.000 claims description 2
- DSDVUXRTYBTVRN-UHFFFAOYSA-N dimethyl(tetradecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCC[NH+](C)C DSDVUXRTYBTVRN-UHFFFAOYSA-N 0.000 claims 1
- -1 sodium amide Chemical class 0.000 abstract description 8
- 238000000605 extraction Methods 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 9
- NQQRXZOPZBKCNF-NSCUHMNNSA-N (e)-but-2-enamide Chemical compound C\C=C\C(N)=O NQQRXZOPZBKCNF-NSCUHMNNSA-N 0.000 description 8
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- 229940043265 methyl isobutyl ketone Drugs 0.000 description 5
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 1
- ODGIMMLDVSWADK-UHFFFAOYSA-N 4-trifluoromethylaniline Chemical compound NC1=CC=C(C(F)(F)F)C=C1 ODGIMMLDVSWADK-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000002739 cryptand Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- ULWOJODHECIZAU-UHFFFAOYSA-N n,n-diethylpropan-2-amine Chemical compound CCN(CC)C(C)C ULWOJODHECIZAU-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 239000007966 viscous suspension Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/32—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/26—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and singly-bound oxygen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/27—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and doubly-bound oxygen atoms bound to the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10311763.6 | 2003-03-18 | ||
| DE10311763A DE10311763A1 (de) | 2003-03-18 | 2003-03-18 | Verfahren zur Herstellung von 2-Cyan-3-hydroxy-N-(phenyl)but-2-enamiden |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2005132162A RU2005132162A (ru) | 2006-02-10 |
| RU2330838C2 true RU2330838C2 (ru) | 2008-08-10 |
Family
ID=32945937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005132162/04A RU2330838C2 (ru) | 2003-03-18 | 2004-03-06 | Способ получения 2-циан-3-гидрокси-n-(фенил) бут-2-енамидов |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1606246B1 (enExample) |
| JP (1) | JP4546952B2 (enExample) |
| KR (1) | KR101072237B1 (enExample) |
| CN (1) | CN100361967C (enExample) |
| AR (1) | AR043624A1 (enExample) |
| AT (1) | ATE468323T1 (enExample) |
| AU (1) | AU2004222139B2 (enExample) |
| CA (1) | CA2519209C (enExample) |
| CY (1) | CY1110722T1 (enExample) |
| DE (2) | DE10311763A1 (enExample) |
| DK (1) | DK1606246T3 (enExample) |
| ES (1) | ES2346215T3 (enExample) |
| IL (1) | IL170934A (enExample) |
| MX (1) | MXPA05009764A (enExample) |
| PL (1) | PL1606246T3 (enExample) |
| PT (1) | PT1606246E (enExample) |
| RU (1) | RU2330838C2 (enExample) |
| SI (1) | SI1606246T1 (enExample) |
| TW (1) | TW200503995A (enExample) |
| WO (1) | WO2004083165A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009147624A2 (en) * | 2008-06-05 | 2009-12-10 | Alembic Limited | A process for preparing teriflunomide |
| CA2861411A1 (en) * | 2012-01-28 | 2013-08-01 | Optmed, Inc. | Improved methylidene malonate process |
| CN104995166A (zh) * | 2013-01-29 | 2015-10-21 | Opt迈德有限公司 | 改进的1,1-二取代的乙烯方法 |
| CN104693070A (zh) * | 2013-12-10 | 2015-06-10 | 深圳翰宇药业股份有限公司 | 一种特立氟胺的合成方法 |
| CN105272882B (zh) * | 2014-07-23 | 2019-05-31 | 欣凯医药化工中间体（上海）有限公司 | 一种环保简便制备泰瑞米特的方法 |
| CN116924937A (zh) * | 2022-04-02 | 2023-10-24 | 江苏康缘药业股份有限公司 | 2-氰基-3-羟基-2-丁烯-(4-三氟甲基-苯基)酰胺制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5519042A (en) * | 1994-01-13 | 1996-05-21 | Hoechst Aktiengesellschaft | Method of treating hyperproliferative vascular disease |
| US5700822A (en) * | 1994-01-07 | 1997-12-23 | The Regents Of The University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8619432D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
| DE19636974A1 (de) * | 1996-09-12 | 1998-03-19 | Hoechst Ag | 2-Cyano-3,5-dihydroxy-hex-2-en- carbonsäureamidderivate |
| WO2002034251A1 (en) * | 2000-10-20 | 2002-05-02 | Parker Hughes Institute | Treatment of asthma with lfm analogues |
-
2003
- 2003-03-18 DE DE10311763A patent/DE10311763A1/de not_active Withdrawn
-
2004
- 2004-03-06 RU RU2005132162/04A patent/RU2330838C2/ru active
- 2004-03-06 DK DK04718192.0T patent/DK1606246T3/da active
- 2004-03-06 PL PL04718192T patent/PL1606246T3/pl unknown
- 2004-03-06 AT AT04718192T patent/ATE468323T1/de active
- 2004-03-06 CA CA2519209A patent/CA2519209C/en not_active Expired - Fee Related
- 2004-03-06 AU AU2004222139A patent/AU2004222139B2/en not_active Expired
- 2004-03-06 KR KR1020057017413A patent/KR101072237B1/ko not_active Expired - Lifetime
- 2004-03-06 JP JP2006504568A patent/JP4546952B2/ja not_active Expired - Lifetime
- 2004-03-06 MX MXPA05009764A patent/MXPA05009764A/es active IP Right Grant
- 2004-03-06 WO PCT/EP2004/002311 patent/WO2004083165A1/de not_active Ceased
- 2004-03-06 SI SI200431463T patent/SI1606246T1/sl unknown
- 2004-03-06 PT PT04718192T patent/PT1606246E/pt unknown
- 2004-03-06 DE DE502004011176T patent/DE502004011176D1/de not_active Expired - Lifetime
- 2004-03-06 EP EP04718192A patent/EP1606246B1/de not_active Expired - Lifetime
- 2004-03-06 CN CNB2004800058365A patent/CN100361967C/zh not_active Expired - Lifetime
- 2004-03-06 ES ES04718192T patent/ES2346215T3/es not_active Expired - Lifetime
- 2004-03-16 AR ARP040100868A patent/AR043624A1/es unknown
- 2004-03-16 TW TW093106897A patent/TW200503995A/zh unknown
-
2005
- 2005-09-18 IL IL170934A patent/IL170934A/en active IP Right Grant
-
2010
- 2010-08-03 CY CY20101100723T patent/CY1110722T1/el unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5700822A (en) * | 1994-01-07 | 1997-12-23 | The Regents Of The University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
| US5519042A (en) * | 1994-01-13 | 1996-05-21 | Hoechst Aktiengesellschaft | Method of treating hyperproliferative vascular disease |
Non-Patent Citations (1)
| Title |
|---|
| SUTAPA GHOSH et al. Three leflunomide metabolite analogs, Acta Crystallographica Section С Crystal Structure Communications, 2000, C56, 1254-1257. * |
Also Published As
| Publication number | Publication date |
|---|---|
| PL1606246T3 (pl) | 2010-10-29 |
| TW200503995A (en) | 2005-02-01 |
| AR043624A1 (es) | 2005-08-03 |
| SI1606246T1 (sl) | 2010-08-31 |
| MXPA05009764A (es) | 2005-10-26 |
| ES2346215T3 (es) | 2010-10-13 |
| WO2004083165A1 (de) | 2004-09-30 |
| EP1606246B1 (de) | 2010-05-19 |
| CA2519209C (en) | 2011-12-06 |
| CA2519209A1 (en) | 2004-09-30 |
| KR20050120647A (ko) | 2005-12-22 |
| JP2006520345A (ja) | 2006-09-07 |
| DE502004011176D1 (de) | 2010-07-01 |
| DE10311763A1 (de) | 2004-10-07 |
| KR101072237B1 (ko) | 2011-10-12 |
| CN1756737A (zh) | 2006-04-05 |
| HK1086818A1 (zh) | 2006-09-29 |
| IL170934A (en) | 2009-11-18 |
| RU2005132162A (ru) | 2006-02-10 |
| AU2004222139A1 (en) | 2004-09-30 |
| EP1606246A1 (de) | 2005-12-21 |
| AU2004222139B2 (en) | 2010-03-04 |
| JP4546952B2 (ja) | 2010-09-22 |
| ATE468323T1 (de) | 2010-06-15 |
| DK1606246T3 (da) | 2010-09-06 |
| CY1110722T1 (el) | 2015-06-10 |
| CN100361967C (zh) | 2008-01-16 |
| PT1606246E (pt) | 2010-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2790924A1 (en) | Processes for the synthesis of diarylthiohydantoin and diarylhydantoin compounds | |
| US10081620B2 (en) | Radioactive fluorine labeling precursor compound and method for manufacturing radioactive fluorine labeled compound using the same | |
| US7442792B2 (en) | Process for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof | |
| RU2330838C2 (ru) | Способ получения 2-циан-3-гидрокси-n-(фенил) бут-2-енамидов | |
| US7241896B2 (en) | Method for producing 2-halogen-pyridine-carboxylic acid amides | |
| KR102487872B1 (ko) | 가용성 구아닐레이트 시클라제 자극제의 신규 제조 방법 | |
| US7541493B2 (en) | Modafinil synthesis process | |
| Jiang et al. | A convenient stereoselective synthesis of trifluoromethyl-substituted polyfunctionalized cyclopropane: synthesis of (±)-trans-trifluoronorcoronamic acid | |
| EP1742922B1 (en) | Crystalline pyrazole derivative | |
| US6894184B2 (en) | Process for preparing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamides | |
| CN112707869B (zh) | 一种达可替尼杂质及其制备方法 | |
| AU2003242638A1 (en) | Method for the production of 1,2,4-triazolylmethyl-oxiranes | |
| US7745664B2 (en) | Processes for preparing venlafaxine and venlafaxine hydrochloride of form I | |
| EP1046635A1 (en) | Process for preparing an aromatic compound substituted by a tertiary nitrile | |
| JP5032732B2 (ja) | 塩素化ピリミジンの合成 | |
| KR101184915B1 (ko) | 고순도 프라수그렐의 제조방법 | |
| JP2000281676A (ja) | Ａｍｐａ拮抗化合物の新規製造法 | |
| HK1086818B (en) | Method for producing 2-cyan-3-hydroxy-n-(phenyl)but-2-ene amides | |
| CA2283230A1 (en) | Method of making arylamino triazolopyridines | |
| JP2024174490A (ja) | ベンジルヒドラジン誘導体の製造方法 | |
| CN114315811A (zh) | 一种三氮唑类似物化合物及其制备方法和应用 | |
| JP2003113151A (ja) | Ｎ−非置換アミジニウム塩 | |
| JPH09118668A (ja) | ２−アルキル−４−クロロ−５−ヒドロキシメチルイミダゾール誘導体の製造法 | |
| JPH10147563A (ja) | α−（ｔｅｒｔ−アルキル）シアノ酢酸のエステルの製造法 | |
| HK1180186B (en) | Processes for the synthesis of diarylthiohydantoin and diarylhydantoin compounds |